SICUR 2026 Brokerage Event - Cluster 3

24–26 Feb 2026 | Madrid, Spain

Genexica Biotech

Company

genexica.gr/Menidi Aetolias-Akarnanias, Greece
4 profile visits

About

At Genexica Biotech, we are dedicated to revolutionizing healthcare through innovative biotechnology solutions. Our cutting-edge research and development efforts focus on creating advanced therapies and diagnostics that address unmet medical needs. By collaborating with industry leaders and fostering partnerships, we aim to accelerate the delivery of game-changing products to market. Together, we are forging a healthier future for patients worldwide.

Disaster-resilient society

HORIZON-CL3-2026-01-DRS-01: Designing new ways of risk awareness and enhanced disaster preparednessHORIZON-CL3-2026-01-DRS-02: Multi-hazard approach and cumulative / cascading impactsHORIZON-CL3-2026-01-DRS-03: Development of innovative tools, processes, equipment and technologies through responses to disasters and emergencies for search and rescue in hazardous conditionsHORIZON-CL3-2026-01-DRS-04: Open topic on driving innovation uptake of disaster risk solutions

Support to Security Research and Innovation 

HORIZON-CL3-2026-01-SSRI-01: Open topic on supporting disruptive technological innovations for civil securityHORIZON-CL3-2026-01-SSRI-02: Demand-led innovation in securityHORIZON-CL3-2026-01-SSRI-03: Public procurement of innovation for security

Resilient Infrastructure

HORIZON-CL3-2026-01-INFRA-03: Targeted innovative capabilities for the resilience of critical entities to natural and human-induced disasters, including hybrid scenarios

Representatives

Remote
Remote

CEO

Genexica Biotech

Marketplace (3)

  • Product

    Rapid Hemostasis Gel Barrier for Emergency and Disaster Response

    Bioactive hemostatic gel forming an instant barrier to stop bleeding in emergency and disaster response, where conventional dressings fail.

    • Other
    • Commercial partners
    • Technological partners
    • Investment opportunities
    • Crisis response and recovery
    • Security against emergencies
    • Weather, climatic and geological disasters
    • Chemical, biological and radiological threats
    • Ships, submarines, police and rescue vessels, other ships
    Author

    CEO at Genexica Biotech

    Menidi Aetolias-Akarnanias, Greece

  • Project cooperation

    Horizon Europe Cluster 3 Cooperation on Rapid Hemostasis Solutions

    Seeking H. E. Cluster 3 partners to co-develop, validate & deploy an innovative hemostasis gel barrier for disaster-resilient society.

    • Innovation Action
    • Disaster-resilient society
    • Fighting Crime and Terrorism
    • Research and Innovation Action
    • Coordination and Support Action
    • Execution - Development stage (preparation)
    Author

    CEO at Genexica Biotech

    Menidi Aetolias-Akarnanias, Greece

  • Partnership

    Strategic Partnership for Emergency Hemostasis Solutions

    Seeking strategic partners to jointly develop, validate & deploy an innovative hemostasis gel barrier for emergency & disaster response.

    • Other
    • Innovation
    • Manufacturing
    • Research and development
    Author

    CEO at Genexica Biotech

    Menidi Aetolias-Akarnanias, Greece